December 08, 2004
Abnormal Brain Anatomy shown in ADHD
Novel Imaging Technique Shows Abnormal Brain Anatomy In Children With ADHD
Children with attention deficit hyperactivity disorder (ADHD) display anatomical brain abnormalities beyond chemical imbalance, according to research presented at the annual meeting of the Radiological Society of North America (RSNA). Stimulant medications prescribed to balance brain chemistry appear to normalize some of these brain irregularities, a second study reported.
"We found abnormality of the fiber pathways in the frontal cortex, basal ganglia, brain stem and cerebellum," said lead author of both studies, Manzar Ashtari, PhD., associate professor of radiology and psychiatry at North Shore-Long Island Jewish Health System in New Hyde Park, N.Y.
Novel Imaging Technique Shows Abnormal Brain Anatomy In Children With ADHD
Children with attention deficit hyperactivity disorder (ADHD) display anatomical brain abnormalities beyond chemical imbalance, according to research presented at the annual meeting of the Radiological Society of North America (RSNA). Stimulant medications prescribed to balance brain chemistry appear to normalize some of these brain irregularities, a second study reported.
"We found abnormality of the fiber pathways in the frontal cortex, basal ganglia, brain stem and cerebellum," said lead author of both studies, Manzar Ashtari, PhD., associate professor of radiology and psychiatry at North Shore-Long Island Jewish Health System in New Hyde Park, N.Y.
"These areas are involved in the processes that regulate attention, impulsive behavior, motor activity, and inhibition-the key symptoms in ADHD children," Dr. Ashtari said. "They are also known to be part of a bigger circuit in the brain that establishes communication between the frontal lobe and cerebellum."
According to the National Institute of Mental Health (NIMH), ADHD affects 3 to 5 percent of children in the United States. Children with ADHD have difficulty controlling their behavior or focusing their attention.
Using diffusion tensor imaging (DTI) to compare 18 children with diagnosed ADHD with 15 control children to evaluate the brain's white-matter fiber development, Dr. Ashtari's team found differences in the brain fiber pathways that transmit and receive information among brain areas.
"Typically ADHD is described as a chemical imbalance, but our research has shown that there may also be subtle anatomical differences in areas of the brain that are important in this disorder," said co-principal investigator Sanjiv Kumra, M.D., a psychiatrist at the Zucker Hillside Hospital in Glen Oaks, N.Y.
In the second study, the researchers found that children who had received stimulant treatment for ADHD had fewer white matter abnormalities than children who did not receive medication.
Patients consisted of two groups, each comprised of 10 children with ADHD. The first group had not taken medication or had been minimally exposed to medications. The second group was exposed to stimulants for an average of 2.5 years. Each of these groups was compared with 10 age- and gender-matched controls. The medicated ADHD children exhibited a normalization effect in fiber pathways of several brain areas.
"The findings from this small, cross-sectional study indicate that the therapeutic effect of stimulants may involve a brain normalization process," Dr. Kumra said.
Most people diagnosed with ADHD in childhood continue to have problems in adolescence and adulthood. "Despite progress in the assessment, diagnosis and treatment of ADHD, this disorder and its treatment have remained controversial," said co-author of the stimulant study, Andrew Adesman, M.D. "This study is yet further proof that children with ADHD differ at a neurobiological level as compared to children without the disorder." Dr. Adesman is chief of developmental and behavioral pediatrics at Schneider Children's Hospital in New Hyde Park, N.Y.
Dr. Ashtari said further studies with larger patient groups must be conducted before offering parents advice for diagnosis or treatment.
Co-authors are Babak Ardekani, Ph.D., Shree Bhaskar, M.D., Tana Clarke, B.S., and Joseph Rhinewine, M.A. (DTI study only). The research was sponsored by an NIMH grant.
RSNA is an association of more than 37,000 radiologists, radiation oncologists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook, Ill.
Editor's Note: The original news release can be found here.
Posted by szadmin at December 8, 2004 12:57 AM
Hi,
The purpose of my comment here is to introduce you to Minami Nutrition who are purveyors of a very high concentration and pure omega-3 supplement. Our brands are the preferred omega-3 products used in many AD/HD studies throughout the world and this enables me to provide medical teams and coaches with evidence based nutrition information pertaining their work with children and adults.
Minami Nutrition has just launched its products into the US market. Please see below for some key messages about our Omega-3 supplements and please visit www.morepa.com for more information.
If you have any interest in finding out more about omega-3's and AD/HD please indicate a date and time that is convenient for me to call you or please feel free to contact me at any time.
Kind regards,
Christopher Speed MND APD
Nutrition Director to the America's
Minami Nutrition
+1 646 823 5007
www.morepa.com
Minami Nutrition Background:
Minami Nutrition's range of Omega-3 fatty acid supplements are unique due to:
Patented EFP™ Status
Molecular distillation is commonly used to purify omega 3 fats from fish oil. Minami Nutrition does not use this method and instead employs a patented Environmentally Friendly Purified (EFP) CO2 distillation process to make the leading pharmaceutical-grade deep sea fish oil range in an environmentally friendly, pure, natural and cost effective way.
Concentration
Due to our EFP status, Minami Nutrition products have an unprecedented concentration of omega 3 fatty acids providing the benefit of fish oil from just one capsule.
Purity
Minami Nutrition supplements are the most pure on the market with omega 3 fatty acids that work best for your current and future loyal customers. All products meet or exceed US standards for contaminants such as mercury, lead, cadmium, PCB’s, pesticides, dioxins and oxidation levels.
Endorsed By The Leading Figures In Omega-3 Research,
Minami Nutrition receives positive affirmation from the leading figures in omega-3 and nutrition research due to its rigorous attention to detail and for providing the world with the best quality and most efficacious fish oil supplements.
Formulation
We engage the leading world figures in nutrition and omega 3 fatty acid research to assist us to develop our product range so that your customers can take away the full benefits of the fish oils they consume.
No Saturated Fat Or Trans Fat
There are no saturated fats in Minami Nutrition fish oils and due to the use of a low temperature EFP* CO2 distillation process there are no risks of Trans fats.
Taste
Minami Nutrition prides itself on providing a great tasting supplement with no fishy aftertaste with added natural fruit flavors like orange and strawberry.
___________________________________
Christopher Speed
646 823 5007
Posted by: Chrstopher Speed at June 5, 2006 04:18 PM